vs
艾伯维（ARGX）与Raymond James Financial（RJF）财务数据对比。点击上方公司名可切换其他公司
Raymond James Financial的季度营收约是艾伯维的1.6倍（$3.9B vs $2.5B），艾伯维净利率更高（35.5% vs 14.1%，领先21.4%），艾伯维同比增速更快（83.2% vs 13.0%）
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业，研发生产的药物覆盖多种疾病治疗领域，可满足多元临床需求，致力于为全球不同病症的患者提供可靠的治疗方案选择。
雷蒙德詹姆斯金融是美国跨国独立投资银行及金融服务机构，通过旗下子公司为个人、企业及市政主体提供多元金融服务，核心业务覆盖投资与财务规划、投资银行、资产管理等领域，总部位于美国佛罗里达州圣彼得堡。
ARGX vs RJF — 直观对比
营收规模更大
RJF
是对方的1.6倍
$2.5B
营收增速更快
ARGX
高出70.2%
13.0%
净利率更高
ARGX
高出21.4%
14.1%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $3.9B |
| 净利润 | $877.2M | $544.0M |
| 毛利率 | 89.5% | — |
| 营业利润率 | 28.9% | — |
| 净利率 | 35.5% | 14.1% |
| 营收同比 | 83.2% | 13.0% |
| 净利润同比 | 1.3% | 10.0% |
| 每股收益（稀释后） | $13.25 | $2.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARGXRJF
| Q1 26 | — | $3.9B | ||
| Q4 25 | $2.5B | $4.2B | ||
| Q3 25 | — | $4.2B | ||
| Q2 25 | $1.8B | $3.8B | ||
| Q1 25 | — | $3.8B | ||
| Q4 24 | $1.4B | $4.0B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | $901.9M | $3.8B |
净利润ARGXRJF
| Q1 26 | — | $544.0M | ||
| Q4 25 | $877.2M | $563.0M | ||
| Q3 25 | — | $604.0M | ||
| Q2 25 | $414.8M | $436.0M | ||
| Q1 25 | — | $495.0M | ||
| Q4 24 | $865.6M | $600.0M | ||
| Q3 24 | — | $602.0M | ||
| Q2 24 | $-32.5M | $492.0M |
毛利率ARGXRJF
| Q1 26 | — | — | ||
| Q4 25 | 89.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 89.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 90.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 89.4% | — |
营业利润率ARGXRJF
| Q1 26 | — | — | ||
| Q4 25 | 28.9% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 19.2% | 14.7% | ||
| Q1 25 | — | 17.5% | ||
| Q4 24 | 8.7% | 18.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | -15.4% | 17.1% |
净利率ARGXRJF
| Q1 26 | — | 14.1% | ||
| Q4 25 | 35.5% | 13.5% | ||
| Q3 25 | — | 14.4% | ||
| Q2 25 | 23.4% | 11.3% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | 64.1% | 14.9% | ||
| Q3 24 | — | 15.0% | ||
| Q2 24 | -3.6% | 13.1% |
每股收益（稀释后）ARGXRJF
| Q1 26 | — | $2.83 | ||
| Q4 25 | $13.25 | $2.79 | ||
| Q3 25 | — | $2.96 | ||
| Q2 25 | $6.32 | $2.12 | ||
| Q1 25 | — | $2.36 | ||
| Q4 24 | $13.33 | $2.86 | ||
| Q3 24 | — | $2.85 | ||
| Q2 24 | $-0.55 | $2.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5B | $5.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3B | $52.0M |
| 总资产 | $8.7B | $91.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARGXRJF
| Q1 26 | — | $5.4B | ||
| Q4 25 | $3.5B | $9.9B | ||
| Q3 25 | — | $11.4B | ||
| Q2 25 | $2.1B | $9.2B | ||
| Q1 25 | — | $9.7B | ||
| Q4 24 | $1.5B | $10.0B | ||
| Q3 24 | — | $11.0B | ||
| Q2 24 | $1.4B | $9.1B |
总债务ARGXRJF
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $11.0M | — |
股东权益ARGXRJF
| Q1 26 | — | $52.0M | ||
| Q4 25 | $7.3B | $12.6B | ||
| Q3 25 | — | $12.5B | ||
| Q2 25 | $6.1B | $12.3B | ||
| Q1 25 | — | $12.2B | ||
| Q4 24 | $5.5B | $11.9B | ||
| Q3 24 | — | $11.7B | ||
| Q2 24 | $4.3B | $11.2B |
总资产ARGXRJF
| Q1 26 | — | $91.9B | ||
| Q4 25 | $8.7B | $88.8B | ||
| Q3 25 | — | $88.2B | ||
| Q2 25 | $7.2B | $84.8B | ||
| Q1 25 | — | $83.1B | ||
| Q4 24 | $6.2B | $82.3B | ||
| Q3 24 | — | $83.0B | ||
| Q2 24 | $4.8B | $80.6B |
负债/权益比ARGXRJF
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $323.3M | — |
| 自由现金流经营现金流 - 资本支出 | $322.4M | — |
| 自由现金流率自由现金流/营收 | 13.0% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 0.37× | — |
| 过去12个月自由现金流最近4个季度 | $594.5M | — |
8季度趋势，按日历期对齐
经营现金流ARGXRJF
| Q1 26 | — | — | ||
| Q4 25 | $323.3M | $-10.0M | ||
| Q3 25 | — | $796.0M | ||
| Q2 25 | $361.8M | $691.0M | ||
| Q1 25 | — | $117.0M | ||
| Q4 24 | $41.9M | $830.0M | ||
| Q3 24 | — | $510.0M | ||
| Q2 24 | $-124.7M | $711.0M |
自由现金流ARGXRJF
| Q1 26 | — | — | ||
| Q4 25 | $322.4M | $-56.0M | ||
| Q3 25 | — | $752.0M | ||
| Q2 25 | $356.6M | $634.0M | ||
| Q1 25 | — | $71.0M | ||
| Q4 24 | $40.9M | $789.0M | ||
| Q3 24 | — | $460.0M | ||
| Q2 24 | $-125.5M | $655.0M |
自由现金流率ARGXRJF
| Q1 26 | — | — | ||
| Q4 25 | 13.0% | -1.3% | ||
| Q3 25 | — | 17.9% | ||
| Q2 25 | 20.1% | 16.5% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | 3.0% | 19.6% | ||
| Q3 24 | — | 11.5% | ||
| Q2 24 | -13.9% | 17.4% |
资本支出强度ARGXRJF
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 1.1% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | 0.3% | 1.5% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | 0.1% | 1.0% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | 0.1% | 1.5% |
现金转化率ARGXRJF
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | -0.02× | ||
| Q3 25 | — | 1.32× | ||
| Q2 25 | 0.87× | 1.58× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | 0.05× | 1.38× | ||
| Q3 24 | — | 0.85× | ||
| Q2 24 | — | 1.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARGX
暂无分部数据
RJF
| Private Client Group | $2.8B | 73% |
| Bank | $486.0M | 13% |
| Capital Markets | $464.0M | 12% |
| Other | $99.0M | 3% |
